Excel Venture Management builds companies that apply transformative life science technologies to solve problems in healthcare and beyond. The Excel investment portfolio is balanced across healthcare IT and services, diagnostics, and medical devices, plus life science platforms that address adjacent markets including energy, chemicals, defense and agriculture. The majority of the team's prior investments, which include some of the world's premier healthcare and life science companies, are thriving and over half have achieved successful exits generating billions in value.
50
Total Investments
32
Portfolio Companies
-
Exits
2
Industries
General Information
Industries
Biotechnology, Health Care
Funding Stage
Seed +3
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About Excel Venture Management
Recent Investments (50)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series D | •••••• | Oct 2023 | |
| Growth Equity Vc | •••••• | Jan 2021 | |
| Series B | •••••• | May 2020 | |
| Private Equity Round | •••••• | Jan 2020 | |
| Series A | •••••• | Jan 2019 | |
|
|
Series A | •••••• | Dec 2018 |
|
|
Series E | •••••• | Nov 2018 |
|
|
Venture Round | •••••• | Sep 2018 |
|
|
Series D | •••••• | Mar 2017 |
|
|
Series B | •••••• | Dec 2016 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.